Numinus to Participate in Upcoming Investor Conferences in September 2021

Rhea-AI Summary

Numinus Wellness Inc. (TSXV: NUMI), a leader in mental health care using psychedelic-assisted therapies, will participate in two virtual investor conferences in September 2021. The first is the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, where CEO Payton Nyquvest will provide an on-demand presentation starting September 13 at 7:00 a.m. ET. The second is the Cantor Fitzgerald Global Healthcare Conference from September 27-30, featuring a live presentation on September 27 at 2:00 p.m. ET. For more details, visit Numinus Wellness.

VANCOUVER, BC, Sept. 2, 2021 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in two upcoming investor conferences:

• H.C. Wainwright 23^rd Annual Global Investment Conference, to be held virtually on September 13-15, 2021. A presentation by Payton Nyquvest, Founder and CEO of Numinus, will be available on-demand starting Monday, September 13^th at 7:00 a.m. ET.
• Cantor Fitzgerald Global Healthcare Conference, to be held virtually on September 27-30, 2021. Mr. Nyquvest will present on Monday, September 27^th at 2:00 p.m. ET. The presentation will be webcast live and available for 90 days thereafter at the following link:
  https://wsw.com/webcast/cantor12/numi.v/2365090

For more information about the conferences, or to schedule a one-on-one meeting with Numinus' management, please contact your appropriate representative directly, or send an email to H.C. Wainwright at lk@hcwco.com, Cantor at corporateaccess@cantor.com, or KCSA Strategic Communications at NuminusIR@kcsa.com. 

About Numinus
Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society. 

Learn more at www.numinuswellness.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.

Forward-Looking Statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/numinus-to-participate-in-upcoming-investor-conferences-in-september-2021-301368115.html

SOURCE Numinus Wellness Inc.

FAQ

What are the dates for the Numinus Wellness investor conferences in September 2021?

Numinus Wellness will participate in two investor conferences: the H.C. Wainwright Conference from September 13-15 and the Cantor Fitzgerald Conference from September 27-30, 2021.

Who will present at the H.C. Wainwright Conference for Numinus Wellness?

CEO Payton Nyquvest will present at the H.C. Wainwright 23rd Annual Global Investment Conference.

When will Payton Nyquvest's presentation be available for the H.C. Wainwright Conference?

The presentation will be available on-demand starting September 13, 2021, at 7:00 a.m. ET.

What is the timing for the Cantor Fitzgerald Conference presentation by Numinus Wellness?

Payton Nyquvest will present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2021, at 2:00 p.m. ET.

Where can I find more information about the Numinus Wellness investor conferences?

For more information about the conferences, you can visit the Numinus Wellness website or contact H.C. Wainwright or Cantor Fitzgerald directly.